1[1]Glupczynk Y. Antimicrobial resistance in Helicobacter pylori:a global overview. In Hunt RH,Tytgat GNJ,Editors. Helicobacter pylori:basic mechan isms to clinical cure. Dordrecht:Kluwer,1998. 398～415.
2[2]Ling TKW,Cheng AFB,Sung JJY,et al. An Increase in Helicobacter p ylori strains resistant to metronidazole:a five-year study. Helicobacter,1996 ,2(1):57～61.
3[3]Tytgat GNJ. Aspects of anti-Helicobacter pylori eradication th erapy. In Hunt RH,Tytgat GNJ,Editors. Helicobacter pylori:basic mechanisms t o clinical cure. Dordrecht:Kluwer,1996. 340～347.
4[4]Smith SI,Oyedeji KS,Arigbabu AO,et al. High amoxycillin resistan ce in Helicobacter pylori isolated from gastritis and peptic ulcer patients in Western Nigeria. J Gastroenterol 2001,36(1):67～68.
5[5]Erah PO,Goddard AF,Barret DA,et al. The stability of amoxycillin ,clarithromycin and metronidazole in gastric juice:relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother,1997,39(1):5～12.
6[6]Labenz J,Leverkus F,Borsch G,et al. Omeprazole plus amoxicillin for cureof Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994,29(12):1070～1075.
7[7]Broutet N,Tchamgoue S,Pereira E,et al. Risk factors for failure of Helicobacter pylori eradication therapy. In Hunt RH,Tytgat GNJ,Editors. He licobacter pylori:basic mechanisms to clinical cure. Dordrecht:Kluwer,2000. 60 1～607.
8[8]Graham DY,Lew GM,Malaty HM,et al. Factors influencing the eradic ation of Helicobacter pylori with triple therapy. Gastroenterology 1992,102( 2):493～496.
